...Good afternoon. I'm Pete Salzmann, Chief Executive Officer and a Director of Immunovant. I'm very happy to welcome you to the Immunovant 2020 Stockholders' Meeting. Before I call the meeting to order, I'd like to introduce you to the other members of the Board and the executive leadership team who are joining me virtually today. The other members of the Board on the call include Frank Torti, our Board Chairperson; as well as Doug Hughes; George Migausky; Atul Pande and Eric Venker. The executive officers of Immunovant here today are Pam Connealy, our Chief Financial Officer; Julia Butchko, our Chief Development and Technology Officer; and Brad Middlekauff, our General Counsel and Secretary. Also present are Tony Torrington and Joel Wagner from Ernst & Young LLP, Immunovant's auditor. I will be acting as Chairperson of this meeting. Brad Middlekauff will act as secretary of this meeting. The meeting will now officially come to order. We will proceed with the formal business of the meeting...
